| Literature DB >> 35207501 |
Michele Altomare1,2, Shir Sara Bekhor3, Stefano Piero Bernardo Cioffi1, Marco Sacchi4, Federica Renzi1, Andrea Spota1, Roberto Bini1, Federico Ambrogi5, Federico Pozzi6, Arturo Chieregato6, Osvaldo Chiara1,3, Stefania Cimbanassi1,3.
Abstract
BACKGROUND: Organ donation (OD) remains the only therapeutic option for end-stage disease in some cases. Unfortunately, the gap between donors and recipients is still substantial. Trauma patients represent a potential yet underestimated pool of organ donors. In this article, we present our data on OD after damage control strategy (DCS).Entities:
Keywords: damage control; damage control surgery; organ donation; trauma; trauma donors
Year: 2022 PMID: 35207501 PMCID: PMC8877798 DOI: 10.3390/life12020214
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Demographic Characteristics.
| Patient ID | SEX | AGE | BMI | CCI * | Intentionality | Mechanism of Trauma |
|---|---|---|---|---|---|---|
| 1 | M | 31 | 21.10 | 0 | N | Blunt |
| 2 | F | 62 | 31.20 | 2 | N | Blunt |
| 3 | M | 46 | 22.50 | 0 | N | Blunt |
| 4 | M | 60 | 24.80 | 2 | N | Blunt |
| 5 | M | 59 | 23.40 | 1 | N | Blunt |
| 6 | F | 79 | 29.10 | 3 | N | Blunt |
| 7 | M | 34 | 22.90 | 0 | N | Blunt |
| 8 | M | 79 | 24.60 | 3 | N | Blunt |
| 9 | M | 15 | 21.50 | 0 | N | Blunt |
| 10 | M | 57 | 27.50 | 1 | N | Blunt |
| 11 | F | 32 | 18.40 | 0 | N | Blunt |
| 12 | M | 69 | 27.00 | 2 | N | Blunt |
| 13 | M | 18 | 22.40 | 0 | N | Blunt |
| 14 | M | 76 | 24.00 | 5 | N | Blunt |
| 15 | F | 66 | 20.50 | 2 | N | Blunt |
| 16 | M | 26 | 27.70 | 0 | N | Blunt |
| 17 | M | 59 | 26.10 | 1 | Y | Blunt |
| 18 | M | 67 | 23.40 | 2 | N | Blunt |
| 19 | F | 51 | 22.00 | 1 | Y | Penetrating |
| 20 | F | 31 | 22.50 | 0 | N | Blunt |
| 21 | M | 15 | 19.00 | 0 | Y | Blunt |
| 22 | M | 18 | 27.30 | 0 | N | Blunt |
| 23 | M | 42 | 26.30 | 0 | N | Blunt |
| 24 | F | 44 | 21.50 | 0 | N | Blunt |
| 25 | M | 24 | 24.90 | 0 | N | Blunt |
| 26 | M | 22 | 22.90 | 0 | N | Blunt |
| 27 | M | 65 | 26.10 | 2 | N | Blunt |
| 28 | M | 61 | 26.10 | 2 | N | Blunt |
| 29 | F | 23 | 23.00 | 0 | N | Blunt |
| 30 | M | 25 | 23.10 | 0 | N | Blunt |
* Charlton Comorbidity Index; Body mass index.
Pre-hospital rescue data (PH).
| Patient ID | SBP * | HR ° | GCS # | N ° Caridac Arrest | Vasoactive | Time-Prehosp to TC ** (MIN) | EI § |
|---|---|---|---|---|---|---|---|
| 1 | 100 | 100 | 3 | 0 | N | 17 | Y |
| 2 | 150 | 80 | 6 | 0 | N | n/a | Y |
| 3 | 110 | 80 | 3 | 0 | N | n/a | Y |
| 4 | 140 | 85 | 10 | 0 | N | 27 | N |
| 5 | 160 | 180 | 15 | 0 | N | 35 | Y |
| 6 | 120 | 80 | 7 | 0 | N | n/a | Y |
| 7 | 60 | 90 | 3 | 0 | Y | n/a | Y |
| 8 | 180 | 120 | 3 | 0 | N | n/a | Y |
| 9 | 88 | 134 | 3 | 1 | Y | n/a | Y |
| 10 | n/a | 80 | 3 | 0 | N | n/a | Y |
| 11 | 116 | 65 | 3 | 0 | N | n/a | Y |
| 12 | 0 | 0 | 3 | 1 | Y | n/a | Y |
| 13 | 100 | 80 | 3 | 1 | Y | n/a | Y |
| 14 | 80 | 80 | 3 | 0 | N | n/a | Y |
| 15 | 120 | 120 | 3 | 0 | N | 70 | Y |
| 16 | 70 | 130 | 6 | 1 | N | 50 | Y |
| 17 | 140 | 165 | 3 | 0 | N | 160 | N |
| 18 | 150 | 118 | 3 | 1 | Y | 60 | Y |
| 19 | 50 | 120 | 4 | 1 | Y | 180 | Y |
| 20 | 50 | 120 | 3 | 0 | N | 70 | Y |
| 21 | 60 | 55 | 3 | 2 | Y | n/a | Y |
| 22 | 50 | 120 | 3 | 0 | Y | 60 | Y |
| 23 | 120 | 70 | 4 | 0 | N | n/a | Y |
| 24 | 64 | n/a | 3 | 4 | N | n/a | Y |
| 25 | 140 | 80 | 5 | 0 | N | 50 | Y |
| 26 | 60 | 140 | 3 | 0 | N | 70 | Y |
| 27 | 160 | 80 | 5 | 0 | N | n/a | Y |
| 28 | 0 | 0 | 3 | 1 | Y | 85 | Y |
| 29 | 0 | 0 | 3 | 2 | Y | 70 | Y |
| 30 | 0 | 0 | 3 | 2 | Y | n/a | Y |
* Systolic blood pressure; ° Heart rate; # Glasgow Coma Scale; § Endotracheal Intubation; ** Trauma Center.
SR presentation data.
| Patient ID | Cardiac Arrest | Time to ROSC (MIN) | SBP * | HR ° | GCS # | Shock Class | Shock Index | PH | BE $ | LAC £ |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | N | 85 | 140 | 3T | 3 | 1.65 | 7.2 | −5 | 3.2 | |
| 2 | N | 150 | 90 | 3T | 2 | 0.60 | 7.3 | −5.5 | 1.5 | |
| 3 | N | 136 | 70 | 3T | 2 | 0.51 | 7.2 | −7 | 4.2 | |
| 4 | N | 194 | 69 | 3 | 2 | 0.36 | 7.3 | −3.6 | 2.08 | |
| 5 | N | 140 | 113 | 3T | 2 | 0.81 | 7.3 | 2 | 1.99 | |
| 6 | N | 180 | 74 | 3T | 2 | 0.41 | 7.4 | 0 | 2.2 | |
| 7 | N | 70 | 90 | 3T | 3 | 1.29 | 7.1 | −10 | 9.7 | |
| 8 | N | 180 | 126 | 3T | 2 | 0.70 | 7.2 | 2.6 | 1.8 | |
| 9 | N | 104 | 126 | 3T | 3 | 1.21 | 6.94 | −14 | 7.6 | |
| 10 | N | 156 | 80 | 3T | 1 | 0.51 | 6.9 | −17 | 4.4 | |
| 11 | N | 110 | 100 | 3T | 2 | 0.91 | 7 | −14 | 5 | |
| 12 | N | 40 | 75 | 3T | 4 | 1.88 | 7.1 | −11.9 | 5.9 | |
| 13 | N | 112 | 91 | 3T | 3 | 0.81 | 7,4 | 1.6 | 1.1 | |
| 14 | N | 80 | 80 | 3T | 3 | 1.00 | 7.2 | −8.9 | 6.3 | |
| 15 | N | 125 | 98 | 3T | 1 | 0.78 | 7.3 | −4.7 | 3 | |
| 16 | Y | 18 | 40 | 0 | 3T | 4 | 0 | 6.5 | −29 | 15.4 |
| 17 | N | 130 | 180 | 3 | 2 | 1.38 | 6.8 | −16.8 | 8.5 | |
| 18 | N | 70 | 120 | 3T | 3 | 1.71 | 6.9 | −14.5 | 1.1 | |
| 19 | Y | 15 | 120 | 61 | 3T | 1 | 0.51 | 7 | −19.3 | 14.6 |
| 20 | N | 100 | 122 | 3T | 2 | 1.22 | 7 | −13.8 | 8.96 | |
| 21 | Y | 5 | 100 | 150 | 3T | 2 | 1.50 | 7.1 | −15.2 | 16.4 |
| 22 | N | 60 | 134 | 3T | 4 | 2.23 | 7 | −16 | 6 | |
| 23 | N | 134 | 98 | 3T | 2 | 0.73 | 7.3 | 4.8 | 1.4 | |
| 24 | Y | 5 | 90 | 100 | 3T | 3 | 1.11 | 7.3 | −6.9 | 7.9 |
| 25 | N | 120 | 80 | 3T | 1 | 0.67 | 7.2 | −9.2 | 7.9 | |
| 26 | N | 109 | 140 | 3T | 4 | 1.28 | 7.3 | −6.4 | 3.5 | |
| 27 | N | 101 | 73 | 3T | 2 | 0.72 | 7.3 | −3.2 | 2.6 | |
| 28 | N | 100 | 110 | 3T | 2 | 1.10 | 7.3 | −7.2 | 4.9 | |
| 29 | Y | 20 | 70 | 120 | 3T | 4 | 1.71 | 6.6 | −30 | 17 |
| 30 | N | 150 | 87 | 3T | 2 | 0.58 | 6.8 | −19 | 11 |
* Systolic blood pressure; ° Heart rate; # Glasgow Coma Scale; $ Base Excess; £ Lactate.